You are using an older browser version. Please use a supported version for the best MSN experience.

JNJ’s single-dose vaccine ‘has the potential to be a game changer’

Dr. Jesse Pelletier, President of Halodine, joins Yahoo Finance’s Kristin Myers to discuss the latest coronavirus developments and the FDA considering Johnson and Johnson’s single-shot-dose vaccine.


More From Yahoo! Finance

More From Yahoo! Finance

image beaconimage beaconimage beacon